A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)

NCT02059161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

508

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: MK-1293
DRUG: Lantus™
DRUG: Prandial Insulin

Sponsor

Merck Sharp & Dohme LLC